An update had been posted at Clinical Trials on the GVHD (Graft-Vs-Host-Disease) study. The first study record was posted 4/12/16. Results were submitted on 2/14/24 and posted 3/12/24. It was intended to have 60 subjects, however, they only had 6 in the LL arm and 5 placebo. The study was terminated due to lack of enrollment.
The only reason I am posting this is to show that some CYDY personnel are “taking care of business” (as Elvis would say), even when there are other pressing matters and not many employees.
For those interested in the details, you can get a little info about results such as adverse events, however, the number of subjects is so small, the results may not be meaningful. Perhaps one of our “heavy-weights” will let us know if there are any significant items in the (very limited) results.
https://clinicaltrials.gov/study/NCT02737306?...ab=results
The only reason I am posting this is to show that some CYDY personnel are “taking care of business” (as Elvis would say), even when there are other pressing matters and not many employees.
For those interested in the details, you can get a little info about results such as adverse events, however, the number of subjects is so small, the results may not be meaningful. Perhaps one of our “heavy-weights” will let us know if there are any significant items in the (very limited) results.
https://clinicaltrials.gov/study/NCT02737306?...ab=results
9
